Abstract
Scientists recently made a significant breakthrough in the recognition of pathogens via guanylate binding protein 1 (GBP1). Wandel et al. [1] in Nature Immunology described their findings where GBP1 acts as a pattern recognition receptor that directly connects to lipopolysaccharide (LPS). GBP1 identifies gram-negative bacteria such as the enteric pathogen, Salmonella enterica serovar Typhimurium, that enter the cytoplasm of the host cell. GBP1 then quickly connects to LPS and stimulates the assembly of more GBPs in the order of GBP2, GBP3, and GBP4. Subsequently, inflammatory caspase-4 arrives at the GBP1–4 activation platform. Next, the activated caspase-4 drives the cleavage of Gasdermin D, triggering the release of the pro-inflammatory cytokine, interleukin-18 (IL-18) leading to inflammatory pyroptosis and cell death. Not only do these remarkable results expand our current understanding of GBP1, but they also carry the potential to develop therapeutic targets for inflammasome-mediated human disorders.
References
Wandel, M. P., Kim, B. H., Park, E. S., Boyle, K. B., Nayak, K., Lagrange, B., Herod, A., Henry, T., Zilbauer, M., Rohde, J., MacMicking, J. D., & Randow, F. (2020). Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms. Nature Immunology, 21(8), 880–891. https://doi.org/10.1038/s41590-020-0697-2.
Fisch, D., Bando, H., Clough, B., Hornung, V., Yamamoto, M., Shenoy, A. R., Frickel, E. M. (2019). Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis. The EMBO Journal, 38(13). https://doi.org/10.15252/embj.2018100926.
Kutsch, M., Coers, J. (2020). Human guanylate binding proteins: nanomachines orchestrating host defense. The FEBS Journal. https://doi.org/10.1111/febs.15662.
Honkala, A. T., Tailor, D., & Malhotra, S. V. (2019). Guanylate-binding protein 1: An emerging target in inflammation and cancer. Frontiers in Immunology, 10, 3139. https://doi.org/10.3389/fimmu.2019.03139.
Qiu, X., Guo, H., Yang, J., Ji, Y., Wu, C. S., & Chen, X. (2018). Down-regulation of guanylate binding protein 1 causes mitochondrial dysfunction and cellular senescence in macrophages. Scientific Reports, 8(1), 1679 https://doi.org/10.1038/s41598-018-19828-7.
Santos, J. C., Dick, M. S., Lagrange, B., Degrandi, D., Pfeffer, K., Yamamoto, M., Meunier, E., Pelczar, P., Henry, T., & Broz, P. (2018). LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation. The EMBO Journal, 37, e98089. https://doi.org/10.15252/embj.201798089.
Santos, J. C., Boucher, D., Schneider, L. K., Demarco, B., Dilucca, M., Shkarina, K., Heilig, R., Chen, K. W., Lim, R. Y. H., & Broz, P. (2020). Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria. Nature Commmunications, 11(1), 3276. https://doi.org/10.1038/s41467-020-16889-z.
Zheng, D., Liwinski, T., Elinav, E. (2020). Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discovery, 6(36). https://doi.org/10.1038/s41421-020-0167-x.
Gomes, M. T. R., Cerqueira, D. M., Guimarães, E. S., Campos, P. C., & Oliveira, S. C. (2019). Guanylate-binding proteins at the crossroad of noncanonical inflammasome activation during bacterial infections. Journal of Leukocyte Biology, 106, 553–562. https://doi.org/10.1002/JLB.4MR0119-013R.
Hosseinian, N., Cho, Y., Lockey, R. F., & Kolliputi, N. (2015). The role of the NLRP3 inflammasome in pulmonary diseases. Therapeutic Advances in Respiratory Disease, 9(4), 188–197. https://doi.org/10.1177/1753465815586335.
Zhaolin, Z., Guohua, L., Shiyuan, W., & Zuo, W. (2019). Role of pyroptosis in cardiovascular disease. Cell Proliferation in Basic and Clinical Sciences, 52(2), e12563. https://doi.org/10.1111/cpr.12563.
Fisch, D., Clough, B., Domart, M. C., Encheva, V., Bando, H., Snijders, A. P., Collinson, L. M., Yamamoto, M., Shenoy, A. R., & Frickel, E. M. (2020). Human GBP1 differentially targets salmonella and toxoplasma to license recognition of microbial ligands and caspase-mediated death. Cell Reports, 32(6), 108008. https://doi.org/10.1016/j.celrep.2020.108008.
Finethy, R., Jorgensen, I., Haldar, A., Zoete, M., Strowig, T., Flavell, R., Yamamoto, M., Nagarajan, U., Miao, E., & Coers, J. (2015). Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages. Infection and Immunity, 83(12), 4740–9. https://doi.org/10.1128/iai.00856-15.
Bertani, B., Ruiz, N. (2018). Function and Biogenesis of Lipopolysaccharides. EcoSal Plus, 8(1). https://doi.org/10.1128/ecosalplus.ESP-0001-2018.
Feng, S., & Man, S. M. (2020). Captain GBP1: inflammasomes assemble, pyroptotic endgame. Nature Immunology, 21(8), 829–830. https://doi.org/10.1038/s41590-020-0727-0.
Li, T., Zheng, G., Li, B., Tang, L. (2021). Pyroptosis: A promising therapeutic target for noninfectious diseases. Cell Proliferation in Basic and Clinical Sciences. https://doi.org/10.1111/cpr.13137.
Liu, X., Xia, S., Zhang, Z., Wu, H., & Lieberman, J. (2021). Channelling inflammation:gasdermins in physiology and disease. Nature Reviews Drug Discovery, 20, 384–405. https://doi.org/10.1038/s41573-021-00154-z.
Tailor, D., Kumar, V., Pandrala, M., Resendez, A., & Malhotra, S. V. (2018). Inhibiting guanylate binding protein 1 (GBP1) impedes ovarian cancer progression. American Association for Cancer Research, 78(13), 4951. https://doi.org/10.1158/1538-7445.AM2018-4951.
Muhammad, J. S., Jayakumar, M. N., Elemam, N. M., Venkatachalam, T., Raju, T. K., Hamoudi, R. A., & Maghazachi, A. A. (2019). Gasdermin D hypermethylation inhibits pyroptosis and LPS-induced IL-1β release from NK92 cells. ImmunoTargets and Therapy, 8, 29–41. https://doi.org/10.2147/ITT.S219867.
Maldonado, R. F., Sá-Correia, I., & Valvano, M. A. (2016). Lipopolysaccharide modification in gram-negative bacteria during chronic infection. FEMS Microbiology Reviews, 40(4), 480–493. https://doi.org/10.1093/femsre/fuw007.
Acknowledgements
We thank Brenda Flam, Ph.D. (University of South Florida) and Mason Breitzig, MPH (Pennsylvania State University College of Medicine) for comments and revisions on our manuscript.
Funding
The L. Galam laboratory was funded by USF Foundation funds, Joy McCann Culverhouse Chair in Allergy & Immunology and Mabel & Ellsworth Simmons Professorship for Asthma Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Johns, C.E., Galam, L. Guanylate Binding Protein 1 (GBP1): A Key Protein in Inflammatory Pyroptosis. Cell Biochem Biophys 80, 295–299 (2022). https://doi.org/10.1007/s12013-021-01056-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-021-01056-y